Advanz Adds Biosimilars Alliance With Alkem’s Enzene
Firms Strike Exclusive Partnership To Develop And Commercialize Rare Disease Drug
Advanz Pharma has further built out its biosimilars interests by striking a deal with Alkem’s Enzene Biosciences subsidiary to develop and commercialize a rare disease treatment.
